130 related articles for article (PubMed ID: 1716996)
1. Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD.
Zemel D; Krediet RT; Koomen GC; Struijk DG; Arisz L
Perit Dial Int; 1991; 11(3):217-23. PubMed ID: 1716996
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane.
Zemel D; ten Berge RJ; Struijk DG; Bloemena E; Koomen GC; Krediet RT
Clin Nephrol; 1992 Feb; 37(2):97-103. PubMed ID: 1551256
[TBL] [Abstract][Full Text] [Related]
3. Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis.
Ho-dac-Pannekeet MM; Koopmans JG; Struijk DG; Krediet RT
Adv Perit Dial; 1997; 13():72-6. PubMed ID: 9360654
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients.
Balafa O; Halbesma N; Struijk DG; Dekker FW; Krediet RT
Clin J Am Soc Nephrol; 2011 Mar; 6(3):561-6. PubMed ID: 21071518
[TBL] [Abstract][Full Text] [Related]
5. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733
[TBL] [Abstract][Full Text] [Related]
6. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
[TBL] [Abstract][Full Text] [Related]
7. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
[TBL] [Abstract][Full Text] [Related]
8. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.
Douma CE; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1997 Jun; 51(6):1885-92. PubMed ID: 9186879
[TBL] [Abstract][Full Text] [Related]
9. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
Douma CE; de Waart DR; Struijk DG; Krediet RT
Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis.
Kabanda A; Goffin E; Bernard A; Lauwerys R; van Ypersele de Strihou C
Kidney Int; 1995 Dec; 48(6):1946-52. PubMed ID: 8587256
[TBL] [Abstract][Full Text] [Related]
11. The effect of glucose polymers on water removal and protein clearances during CAPD.
Imholz AL; Brown CB; Koomen GC; Arisz L; Krediet RT
Adv Perit Dial; 1993; 9():25-30. PubMed ID: 7692975
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
13. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD.
Imholz AL; Koomen GC; Struijk DG; Arisz L; Krediet RT
Kidney Int; 1993 Jun; 43(6):1339-46. PubMed ID: 8315948
[TBL] [Abstract][Full Text] [Related]
14. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
Radtke M; Albrektsen GE; Widerøe TE; Nilsen TI; Romundstad P; Hallan S; Aasarød K; Laegreid IK; Oien C
Perit Dial Int; 2004; 24(6):571-9. PubMed ID: 15559487
[TBL] [Abstract][Full Text] [Related]
15. Icodextrin's effects on peritoneal transport.
Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
Smit W; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
[TBL] [Abstract][Full Text] [Related]
17. Icodextrin and intraperitoneal inflammation.
Moriishi M; Kawanishi H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients.
Krediet RT; Zuyderhoudt FM; Boeschoten EW; Arisz L
Eur J Clin Invest; 1987 Feb; 17(1):43-52. PubMed ID: 3106050
[TBL] [Abstract][Full Text] [Related]
19. Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD.
Buis B; Koomen GC; Imholz AL; Struijk DG; Reddingius RE; Arisz L; Krediet RT
Nephrol Dial Transplant; 1996 Jun; 11(6):1113-20. PubMed ID: 8671978
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of peritoneal transport in CAPD patients.
Struijk DG; Krediet RT; Koomen GC; Boeschoten EW; Hoek FJ; Arisz L
Kidney Int; 1994 Jun; 45(6):1739-44. PubMed ID: 7523752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
